Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/30/2019 | 03:10am EST

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

30.09.2019 / 09:05
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


- Share buy-back - 15th Interim Report

In the period from September 23, 2019 until and including September 27, 2019, a total of 0 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
23.09.2019 - -
24.09.2019 - -
25.09.2019 - -
26.09.2019 - -
27.09.2019 - -
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including September 27, 2019 therefore amounts to 2,997,001 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., September 30, 2019



30.09.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

882159  30.09.2019 

fncls.ssp?fn=show_t_gif&application_id=882159&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
11/11FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/04FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/04FRESENIUS : Buys Colombia's CediMed in EUR40 Million Investment
DJ
11/01FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
10/31FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section ..
EQ
10/29FRESENIUS MEDICAL CARE : beats third-quarter forecasts with strong sales of home..
RE
10/29FRESENIUS : 3Q Net Profit, Sales Grew; Backs Outlook
DJ
10/29FRESENIUS MEDICAL CARE : appoints Dr. Frank Maddux to Management Board, makes Gl..
EQ
10/29FRESENIUS MEDICAL CARE : again delivers strong organic growth in the third quart..
EQ
10/28FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
More news
Financials (USD)
Sales 2019 19 357 M
EBIT 2019 2 552 M
Net income 2019 1 302 M
Debt 2019 9 268 M
Yield 2019 1,79%
P/E ratio 2019 16,7x
P/E ratio 2020 14,0x
EV / Sales2019 1,60x
EV / Sales2020 1,53x
Capitalization 21 607 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 85,73  $
Last Close Price 72,16  $
Spread / Highest target 54,0%
Spread / Average Target 18,8%
Spread / Lowest Target -32,4%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer